Tumors of the Urinary System

Withrow and MacEwen's Small Animal Clinical Oncology: Fifth Edition

Volumn , Issue , 2012, Pages 572-582

  Knapp, Deborah W ^a   Mcmillan, Sarah K ^b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84877960639     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2362-5.00029-3     Document Type: Chapter

References (94)

1. Mutsaers AJ, Widmer WR, Knapp DW Canine transitional cell carcinoma. J Vet Intern Med 2003, 17:136-144.
2. Knapp DW, Glickman NW, DeNicola DB, et al. Naturally-occurring canine transitional cell carcinoma of the urinary bladder: a relevant model of human invasive bladder cancer. Urol Oncol 2000, 5:47-59.
3. Knapp DW Animal models: naturally occurring canine urinary bladder cancer. Textbook of bladder cancer 2006, Taylor and Francis, Oxon, United Kingdom. S.P. Lerner, M.P. Schoenberg, C.N. Sternberg (Eds.).
4. Valli VE, Norris A, Jacobs RM, et al. Pathology of canine bladder and urethral cancer and correlation with tumour progression and survival. J Comp Pathol 1995, 113:113-130.
5. Gelberg HB Urinary bladder mass in a dog. Vet Pathol 2010, 47:181-184.
6. Kessler M, Kandel-Tschiederer B, Pfleghaar S, et al. Primary malignant lymphoma of the urinary bladder in a dog: long term remission following treatment with radiation and chemotherapy. Schweiz Arch Tierheilkd 2008, 150:565-569.
7. Bae IH, Kim Y, Pakhrin B, et al. Genitourinary rhabdomyosarcoma with systemic metastasis in a young dog. Vet Pathol 2007, 44:518-520.
8. Benigni L, Lamb CR, Corzo-Menendez N, et al. Lymphoma affecting the urinary bladder in three dogs and a cat. Vet Radiol Ultrasound 2006, 47:592-596.
9. Heng HG, Lowry JE, Boston S, et al. Smooth muscle neoplasia of the urinary bladder wall in three dogs. Vet Radiol Ultrasound 2006, 47:83-86.
10. Liptak JM, Dernell WS, Withrow SJ Haemangiosarcoma of the urinary bladder in a dog. Aust Vet J 2004, 82:215-217.
11. Owen LN TNM classification of tumours in domestic animals 1980, World Health Organization, Geneva.
12. Glickman LT, Schofer FS, McKee LJ Epidemiologic study of insecticide exposures, obesity, and risk of bladder cancer in household dogs. J Toxicol Environ Health 1989, 28:407-414.
13. Bryan JN, Keeler MR, Henry CJ, et al. A population study of neutering status as a risk factor for canine prostate cancer. Prostate 2007, 67:1174-1181.
14. Raghavan M, Knapp DW, Dawson MH, et al. Topical spot-on flea and tick products and the risk of transitional cell carcinoma of the urinary bladder in Scottish terrier dogs. J Am Vet Med Assoc 2004, 225:389-394.
15. Glickman LT, Raghavan M, Knapp DW, et al. Herbicide exposure and the risk of transitional cell carcinoma of the urinary bladder in Scottish terrier dogs. J Am Vet Med Assoc 2004, 224:1290-1297.
16. Raghavan M, Knapp DW, Bonney PL, et al. Evaluation of the effect of dietary vegetable consumption on reducing risk of transitional cell carcinoma of the urinary bladder in Scottish terriers. J Am Vet Med Assoc 2005, 227:94-100.
17. Gelberg HB Urinary bladder mass in a dog. Vet Pathol 2010, 47:181-184.
18. Deschamps JY, Roux FA Extravesical textiloma (gossypiboma) mimicking a bladder tumor in a dog. J Am Anim Hosp Assoc 2009, 45:89-92.
19. Böhme B, Ngendahayo P, Hamaide A, et al. Inflammatory pseudotumours of the urinary bladder in dogs resembling human myofibroblastic tumours: a report of eight cases and comparative pathology. Vet J 2010, 183:89-94.
20. Martinez I, Mattoon JS, Eaton KA, et al. Polypoid cystitis in 17 dogs (1978-2001). J Vet Intern Med 2003, 17:499-509.
21. Patrick DJ, Fitzgerald SD, Sesterhenn IA, et al. Classification of canine urinary bladder urothelial tumours based on the World Health Organization/International Society of Urological Pathology Consensus Classification. J Comp Pathol 2006, 135:190-199.
22. Henry CJ, Tyler JW, McEntee MC, et al. Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs. Am J Vet Res 2003, 64:1017-1020.
23. Holak P, Nowicki M, Adamiak Z, et al. Applicability of endoscopic examination as a diagnostic approach in urinary tract ailments in dogs. Pol J Vet Sci 2007, 10:233-238.
24. Messer JS, Chew DJ, McLoughlin MA Cystoscopy: techniques and clinical applications. Clin Tech Small Anim Pract 2005, 20:52-64.
25. Childress MO, Adams LG, Ramos-Vara J, et al. Results of biopsy via transurethral cystoscopy vs cystotomy for diagnosis of transitional cell carcinoma of the urinary bladder and urethra in dogs: 92 cases (2003-2008). J Am Vet Med Assoc 2011, 239:350-356.
26. Vignoli M, Rossi F, Chierici C, et al. Needle tract implantation after fine needle aspiration biopsy (FNAB) of transitional cell carcinoma of the urinary bladder and adenocarcinoma of the lung. Schweiz Arch Tierheilkd 2007, 149:314-318.
27. Nyland TG, Wallack ST, Wisner ER Needle tract implantation following US-guided fine-needle aspiration biopsy of transitional cell carcinoma of the bladder, urethra, and prostate. Vet Radiol Ultrasound 2002, 43:50-53.
28. Ramos-Vara JA, Miller MA, Boucher M, et al. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors. Vet Pathol 2003, 40:55-62.
29. Lai CL, van den Ham R, van Leenders G, et al. Histopathological and immunohistochemical characterization of canine prostate cancer. Prostate 2008, 68:477-488.
30. Chun R, Knapp DW, Widmer WR, et al. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1997, 11:279-283.
31. Hume C, Seiler G, Porat-Mosenco Y, et al. Cystosonographic measurements of canine bladder tumours. Vet Comp Oncol 2010, 8:122-126.
32. Saulnier-Troff FG, Busoni V, Hamaide A A technique for resection of invasive tumors involving the trigone area of the bladder in dogs: preliminary results in two dogs. Vet Surg 2008, 37:427-437.
33. Hautmann RE Ileal bladder substitute. Urologe A 2008, 47:33-40.
34. Stratmann N, Wehrend A Unilateral ovariectomy and cystectomy due to multiple ovarian cysts with subsequent pregnancy in a Belgian shepherd dog. Vet Rec 2007, 160:740-741.
35. Wongsetthachai P, Pramatwinai C, Banlunara W, et al. Urinary bladder wall substitution using autologous tunica vaginalis in male dogs. Res Vet Sci 2011, 90:156-159.
36. Zhang Y, Frimberger D, Cheng EY, et al. Challenges in a larger bladder replacement with cell-seeded and unseeded small intestinal submucosa grafts in a subtotal cystectomy model. BJU Int 2006, 98:1100-1105.
37. Berent AC Ureteral obstructions in dogs and cats: a review of traditional and new interventional diagnostic and therapeutic options. J Vet Emerg Crit Care 2011, 21:86-103.
38. Stone EA, Withrow SJ, Page RL, et al. Ureterocolonic anastomosis in ten dogs with transitional cell carcinoma. Vet Surg 1988, 17:147-153.
39. Smith JD, Stone EA, Gilson SD Placement of a permanent cystostomy catheter to relieve urine outflow obstruction in dogs with transitional cell carcinoma. J Am Vet Med Assoc 1995, 206:496-499.
40. Salinardi BJ, Marks SL, Davidson JR, et al. The use of a low-profile cystostomy tube to relieve urethral obstruction in a dog. J Am Anim Hosp Assoc 2003, 39:403-405.
41. Weisse C, Berent A, Todd K, et al. Evaluation of palliative stenting for management of malignant urethral obstructions in dogs. J Am Vet Med Assoc 2006, 229:226-234.
42. Adams L, McMillan S: Personal communication.
43. Liptak JM, Brutscher SP, Monnet E, et al. Transurethral resection in the management of urethral and prostatic neoplasia in 6 dogs. Vet Surg 2004, 33:505-516.
44. Walker M, Breider M Intraoperative radiotherapy of canine bladder cancer. Vet Radiol 1987, 28:200-204.
45. Withrow SJ, Gillette EL, Hoopes PJ, et al. Intraoperative irradiation of 16 spontaneously occurring canine neoplasms. Vet Surg 1989, 18:7-11.
46. Anderson CR, McNiel EA, Gillette EL, et al. Late complications of pelvic irradiation in 16 dogs. Vet Radiol Ultrasound 2002, 43:187-192.
47. Murphy S, Gutiérrez A, Lawrence J, et al. Laparoscopically implanted tissue expander radiotherapy in canine transitional cell carcinoma. Vet Radiol Ultrasound 2008, 49:400-405.
48. Poirier VJ, Forrest LJ, Adams WM, et al. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study. J Am Anim Hosp Assoc 2004, 40:131-136.
49. Knapp DW, Richardson RC, Chan TCK, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1994, 8:273-278.
50. McMillan SK, Boria P, Moore GE, et al. Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc 2011, 239:1084-1089.
51. Henry CJ, McCaw DL, Turnquist SE, et al. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clin Cancer Res 2003, 9:906-911.
52. Arnold EJ, Childress MO, Fourez LM, et al. Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 2011, 25(6):1385-1390.
53. Chun R, Knapp DW, Widmer WR, et al. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993). J Am Vet Med Assoc 1996, 209:1588-1591.
54. Moore AS, Cardona A, Shapiro W, et al. Cisplatin (cis-diamminedichloroplatinum) for treatment of transitional cell carcinoma of the urinary bladder or urethra: a retrospective study of 15 dogs. J Vet Intern Med 1990, 4:148-152.
55. Greene SN, Lucroy MD, Greenberg CB, et al. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc 2007, 231:1056-1060.
56. Boria PA, Glickman NW, Schmidt BR, et al. Carboplatin and piroxicam in 31 dogs with transitional cell carcinoma of the urinary bladder. Vet Comp Oncol 2005, 3:73-78.
57. Abbo AH, Jones DR, Masters AR, et al. Phase 1 clinical trial and pharmacokinetics of intravesical Mitomycin C in dogs with localized transitional cell carcinoma of the urinary bladder. J Vet Intern Med 2010, 24:1124-1130.
58. Marconato L, Zini E, Lindner D, et al. Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc 2011, 238:1004-1010.
59. Knapp DW, Glickman NW, Widmer WR, et al. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer. Cancer Chemother Pharmacol 2000, 46:221-226.
60. Mohammed SI, Craig BA, Mutsaers AJ, et al. Effects of the cyclooxygenase inhibitor piroxicam in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Mol Cancer Ther 2003, 2:183-188.
61. Knapp D, McMillan S: Personal communication.
62. Knapp D, Henry C: Personal communication.
63. Knapp D, Schrempp D, Leach T: Personal communication.
64. Lu Z, Yeh TK, Wang J, et al. Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy. J Urol 2011, 185:1478-1483.
65. Ridgway TD, Lucroy MD Phototoxic effects of 635-nm light on canine transitional cell carcinoma cells incubated with 5-aminolevulinic acid. Am J Vet Res 2003, 64:131-136.
66. Lucroy MD, Ridgway TD, Peavy GM, et al. Preclinical evaluation of 5-aminolevulinic acid-based photodynamic therapy for canine transitional cell carcinoma. Vet Comp Oncol 2003, 1:76-85.
67. Lucroy M: Personal communication.
68. Schwarz PD, Greene RW, Patnaik AK Urinary bladder tumors in the cat: a review of 27 cases. J Am Anim Hosp Assoc 1985, 21:237-245.
69. Wilson HM, Chun R, Larson VS, et al. Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990-2004). J Am Vet Med Assoc 2007, 231:101-106.
70. Knapp D, McMillan S: Personal communication.
71. Takagi S, Kadosawa T, Ishiguro T, et al. Urethral transitional cell carcinoma in a cat. J Small Anim Pract 2005, 46:504-506.
72. Davis GJ, Holt D Two chondrosarcomas in the urethra of a German shepherd dog. J Small Anim Pract 2003, 44:169-171.
73. Klein MK, Cockerell GL, Withrow SJ, et al. Canine primary renal neoplasms: a retrospective review of 54 cases. J Am Anim Hosp Assoc 1988, 24:443-452.
74. Bryan JN, Henry CJ, Turnquist SE, et al. Primary renal neoplasia of dogs. J Vet Intern Med 2006, 20:1155-1160.
75. Grillo TP, Brandão CV, Mamprim MJ, et al. Hypertrophic osteopathy associated with renal pelvis transitional cell carcinoma in a dog. Can Vet J 2007, 48:745-747.
76. Lingaas F, Comstock KE, Kirkness EF, et al. A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German shepherd dog. Hum Mol Genet 2003, 12:3043-3053.
77. Bonsdorff TB, Jansen JH, Lingaas F Second hits in the FLCN gene in a hereditary renal cancer syndrome in dogs. Mamm Genome 2008, 19:121-126.
78. Bonsdorff TB, Jansen JH, Thomassen RF, et al. Loss of heterozygosity at the FLCN locus in early renal cystic lesions in dogs with renal cystadenocarcinoma and nodular dermatofibrosis. Mamm Genome 2009, 20:315-320.
79. Gil da Costa RM, Oliveira JP, Saraiva AL, et al. Immunohistochemical characterization of 13 canine renal cell carcinomas. Vet Pathol 2011, 48:427-432.
80. Locke JE, Barber LG Comparative aspects and clinical outcomes of canine renal hemangiosarcoma. J Vet Intern Med 2006, 20:962-967.
81. Henry CJ, Turnquist SE, Smith A, et al. Primary renal tumours in cats: 19 cases (1992-1998). J Feline Med Surg 1999, 1:165-170.
82. Klainbart S, Segev G, Loeb E, et al. Resolution of renal adenocarcinoma-induced secondary inappropriate polycythaemia after nephrectomy in two cats. J Feline Med Surg 2008, 10:264-268.
83. Lerner SP, Schoenberg MP, Sternberg CN Textbook of bladder cancer 2006, Taylor and Francis, Oxon, UK.
84. Lin TY, Zhang H, Wang S, et al. Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand. Mol Cancer 2011, 10:9.
85. McCleary-Wheeler AL, Williams LE, Hess PR, et al. Evaluation of an in vitro telomeric repeat amplification protocol assay to detect telomerase activity in canine urine. Am J Vet Res 2010, 71:1468-1474.
86. Lee JY, Tanabe S, Shimohira H, et al. Expression of cyclooxygenase-2, P-glycoprotein and multi-drug resistance-associated protein in canine transitional cell carcinoma. Res Vet Sci 2007, 83:210-216.
87. Rankin WV, Henry CJ, Turnquist SE, et al. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma. Vet Comp Oncol 2008, 6:141-150.
88. Rankin WV, Henry CJ, Turnquist SE, et al. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders. Am J Vet Res 2008, 69:1073-1078.
89. Dill AL, Ifa DR, Manicke NE, et al. Lipid profiles of canine invasive transitional cell carcinoma of the urinary bladder and adjacent normal tissue by desorption electrospray ionization imaging mass spectrometry. Anal Chem 2009, 81:8758-8764.
90. Wilson CR, Regnier FE, Knapp DW, et al. Glycoproteomic profiling of serum peptides in canine lymphoma and transitional cell carcinoma. Vet Comp Oncol 2008, 6:171-181.
91. Dhawan D, Craig BA, Cheng L, et al. Effects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder. Mol Cancer Ther 2010, 9:1371-1377.
92. Chow WH, Dong LM, Devesa SS Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010, 7:245-257.
93. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
94. Pressler BM, Williams LE, Ramos-Vara JA, et al. Sequencing of the von Hippel-Lindau gene in canine renal carcinoma. J Vet Intern Med 2009, 23:592-597.